Raymond James Financial Services Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-14,202
| Closed | -$77K | – | 3046 |
|
|
2020
Q3 | $77K | Buy |
+14,202
| New | +$77K | ﹤0.01% | 2711 |
|
|
2020
Q1 | – | Sell |
-11,217
| Closed | -$45K | – | 2858 |
|
|
2019
Q4 | $45K | Buy |
11,217
+100
| +0.9% | +$401 | ﹤0.01% | 2753 |
|
|
2019
Q3 | $48K | Sell |
11,117
-3,000
| -21% | -$13K | ﹤0.01% | 2692 |
|
|
2019
Q2 | $56K | Sell |
14,117
-4,750
| -25% | -$18.8K | ﹤0.01% | 2724 |
|
|
2019
Q1 | $101K | Buy |
18,867
+2,500
| +15% | +$13.4K | ﹤0.01% | 2638 |
|
|
2018
Q4 | $84K | Sell |
16,367
-900
| -5% | -$4.62K | ﹤0.01% | 2415 |
|
|
2018
Q3 | $167K | Sell |
17,267
-350
| -2% | -$3.39K | ﹤0.01% | 2577 |
|
|
2018
Q2 | $180K | Buy |
17,617
+500
| +3% | +$5.11K | ﹤0.01% | 2509 |
|
|
2018
Q1 | $223K | Buy |
+17,117
| New | +$223K | ﹤0.01% | 2191 |
|
|
2017
Q4 | – | Sell |
-11,133
| Closed | -$279K | – | 2687 |
|
|
2017
Q3 | $279K | Buy |
+11,133
| New | +$279K | ﹤0.01% | 2065 |
|